Intracellular calcium imaging for agonist screening

Haojie Wang1, Bo Yang1, Liangzhu Mo1

  • 1Cyrus Tang Medical Institute, Soochow University, Suzhou 215123, Jiangsu, China.

Biophysics Reports
|July 4, 2025
PubMed

Insights

This study presents a new method for screening drugs that target Calcium Homeostasis Modulator 1 (CALHM1) channels. This research aids in understanding calcium

Area of Science:

  • Physiology
  • Molecular Biology
  • Pharmacology

Background:

  • Calcium ions regulate critical physiological processes including nerve conduction, muscle contraction, cell division, and gene expression via calcium transients and oscillations.
  • Calcium Homeostasis Modulator 1 (CALHM1) is a newly identified plasma membrane ion channel responsible for calcium influx.
  • The identification of CALHM1 agonists and antagonists is crucial for advancing research into calcium-related physiological and pathological conditions and for developing targeted therapeutics.

Purpose of the Study:

  • To establish a comprehensive protocol for detecting real-time calcium dynamics.
  • To facilitate drug screening and validation for novel CALHM1 modulators.
  • To provide a guide for investigating calcium-related physiological processes using calcium imaging techniques.

Main Methods:

  • Utilized genetically encoded calcium indicators in transiently transfected cell lines.
  • Employed calcium indicator dyes in primary cells for calcium dynamics detection.
  • Developed a step-by-step approach for drug screening and validation based on calcium imaging.

Main Results:

  • Successfully demonstrated the detection of real-time calcium dynamics in both cell lines and primary cells.
  • Outlined a comprehensive methodology for screening and validating potential CALHM1-targeting drugs.
  • Validated the utility of calcium imaging for studying calcium-related physiological functions.

Conclusions:

  • The presented protocol offers a valuable tool for researchers studying calcium signaling.
  • This method enables efficient screening and validation of novel CALHM1 agonists and antagonists.
  • The findings support the development of new therapeutic strategies for diseases involving calcium dysregulation.